SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray is trending amid speculation around potential cannabis rescheduling, possibly driven by comments from President Trump, generating significant buzz in the cannabis sector. Community members are actively discussing potential short squeezes and the possibility of the stock reaching much higher valuations. The enthusiasm also stems from potential catalysts that could reshape the industry.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending as the stock approaches its all-time high, driven by optimism around robotaxi advancements and analyst upgrades. Community discussions highlight the potential for a continued rally, while some traders express caution, citing valuation concerns and the possibility of a pullback. Bullish sentiment prevails, with many anticipating a further price increase.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave's stock is facing downward pressure, sparking concerns among investors about its financial health and the broader AI infrastructure sector. Community discussions revolve around insider selling, construction delays, and debt levels, contributing to bearish sentiment despite the company's substantial backlog and long-term potential in AI. Some traders are looking for potential bounces and short-term opportunities, while others remain long-term bulls, citing the company's importance to the AI industry and potential for future growth.

B. Riley Financial, Inc. engages in the provision of financial services and solutions to the capital raising and financial advisory needs of public and private firms. It operates through the following segments: Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications, and Consumer. The Capital Markets segment provides investment banking, corporate finance, research, wealth management, and sales and trading services to corporate, institutional, and high net worth clients. The Wealth Management segment offers retail brokerage, investment management, and insurance, and tax preparation services. The Financial Consulting segment focuses on a variety of specialized advisory services spanning bankruptcy, restructuring, turnaround management, forensic accounting, crisis and litigation support, appraisal and valuation, real estate, and operations management. The Auction and Liquidation segment deals with retail liquidation services. The Communications segment is composed of a portfolio of companies acquired for attractive risk-adjusted investment return characteristics. The Consumer segment includes Targus and the Brands investment portfolio. The company was founded in 1973 and is headquartered in Los Angeles, CA.

B. Riley Financial Inc

B. Riley Financial ($RILY) is trending as traders discuss a potential balance-sheet relief rally and possible short squeeze, with community members highlighting the stock's high short interest and low float. Some are pointing to a potential takeover, while others are focused on a specific catalyst related to Mainz Biomed distribution. The community is also discussing the impact of profitability filings on the stock's future performance.

AMC Robotics Corp. engages in developing and deploying AI-enabled robotics and smart security solutions, especially for warehouse automation, enterprise security, robotics patrol/incident-response and logistics automation. The company is headquartered in New York, NY.

AMC Robotics Corp.

AMCI is trending due to its recent de-SPAC status and resulting momentum, with traders actively discussing its potential for a short squeeze given the high cost to borrow and low float. The community is focused on removing stop losses and setting high limit orders, anticipating a rally similar to SMX. Bullish sentiment is high as traders encourage each other to hold strong and combat perceived short attacks.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as users highlight its strong community and compare it to Bitcoin, emphasizing a culture-focused approach. Discussions revolve around its roots on the Solana blockchain and the potential for growth within the cannabis industry. The community uses terms like "WAGMI" and encourages others to join their X community.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Despite strong fundamentals and expansion news, Luckin Coffee is trending down, frustrating investors. The community is debating whether the recent price action is due to manipulation, large shareholders selling off, or broader market concerns. Some are hopeful for a bounce or relisting catalyst, while others express doubts about management and the company's communication.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid Group is trending amidst mixed sentiment, with community members debating the stock's future and short selling opportunities. Some express concerns over the company's financial performance and leadership, while others highlight positive aspects like the quality of Lucid's vehicles and potential for a short squeeze. Discussions also include comparisons to Chinese EV manufacturers and speculation about potential partnerships or acquisitions.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer's stock is trending due to a softer-than-expected 2026 outlook, with community chatter focusing on declining COVID-19 product sales and upcoming patent expirations; some investors are expressing frustration with management while others see a buying opportunity based on underlying fundamentals and dividend yield. Discussions include analyst target prices, potential M&A activity, and the impact of the CEO's performance.

Advisorshares Trust - AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure US Cannabis ETF

MSOS is trending as the cannabis sector anticipates potential rescheduling, driven by speculation around an upcoming announcement. Community discussions revolve around the potential impact of rescheduling on US cannabis companies, particularly regarding tax benefits and institutional investment. The ETF's price action reflects optimism, with many expecting significant gains if the rescheduling occurs.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$NVAX  Based on the news and data provided on deliveries and EU, Australia, NZ price leak,  seems like Novavax hit the $1 Billion sales/revenue for Q1.  If  there&#39;s 1 batch of 3.2 million doses for Canada and the UK this week, that moves revenue to around 1.15 Billion. Novavax also gets around $200M every quarter in 2021 for grants/royalties.  1st Quarter gross sales could be $1B - $1.3B in the May 9 Q1 report.

Paul Di

e0fknu2k

Ramón de la Vega

Delicious_Aloysius

Tim Chron

Jacked to the twits!

Jerry

Scoop

Moixet

Charging Bull

David G

Louie Gi

Alan

Truth Will Set You Free

Muskington

DarvasBoxing

William L Maltby

Twix

TopShelfStock

Wade

Jose David

Tony Wadie

Skiwp

Álvaro González

Armin Yukihura

Kevin Chan

Alex Johnson

John

Stian Bøhlerengen

Moyses Garcia

StockTwits Web

Novavax Inc

  Based on the news and data provided on deliveries and EU, Australia, NZ price leak,  seems like Novavax hit the $1 Billion sales/revenue for Q1.  If  there's 1 batch of 3.2 million doses for Canada and the UK this week, that moves revenue to around 1.15 Billion. Novavax also gets around $200M every quarter in 2021 for grants/royalties.  1st Quarter gross sales could be $1B - $1.3B in the May 9 Q1 report.

Al Y

@ay8888 thats a very optimistic price per dose because we don&#39;t know how much they are even paying SII for the doses

Keegan

Jo Wu

 thats a very optimistic price per dose because we don't know how much they are even paying SII for the doses

Diego Raul Gonzales Jr. III

@ay8888 Seems reasonable given the guidance NVAX provided that Q1 would approach or even surpass $1B in revenue.  The CFO commentary on COGS being incurred in Q4 bodes well that margins could benefit in Q1/Q2.  So does $1+B revenue finally translate to the 3x or more SP to Revenue that MRNA is showing

 Seems reasonable given the guidance NVAX provided that Q1 would approach or even surpass $1B in revenue.  The CFO commentary on COGS being incurred in Q4 bodes well that margins could benefit in Q1/Q2.  So does $1+B revenue finally translate to the 3x or more SP to Revenue that MRNA is showing

@ay8888 This company has not been transparent with us! The doses produced and doses shipped are just totally do not make any sense. IR will not answer my questions.

StatManDan

 This company has not been transparent with us! The doses produced and doses shipped are just totally do not make any sense. IR will not answer my questions.

@ay8888 i didnt know  about  the 19.2M to india

StockTwits For Android 

Bilvo

$nvax This revenue is in line with analysts target for 4-5 Bilion revenue for 2022, an at this revenue level - analysts are estimating around $200 per share.  EU and Australia/NZ were revealed in the news at $20.90 and $24. Novavax receives grants and royalties every quarter at around $200 million . Some companies use Matrix M for their products.

Paul

Brian Isaacson

StockTwits for iOS

 This revenue is in line with analysts target for 4-5 Bilion revenue for 2022, an at this revenue level - analysts are estimating around $200 per share.  EU and Australia/NZ were revealed in the news at $20.90 and $24. Novavax receives grants and royalties every quarter at around $200 million . Some companies use Matrix M for their products.

@ay8888 Look really accurate...... we need more countries to immediately approve us for booster, get 12-17 age group authorized for more shots, and approvals from Japan, USA, Israel, and S Africa.. 
 
I think we will do at least $2B in Q3 and Q4.    And should do $1.5 to $2B in Q2.....  It&#39;s possible we could do $6.5 to $7.5B if USA gets going on 110 million and approves booster faster for additional orders. 
 
Also, could get more orders now from India and end of year boosters for China.....booster.

 Look really accurate...... we need more countries to immediately approve us for booster, get 12-17 age group authorized for more shots, and approvals from Japan, USA, Israel, and S Africa.. 
 
I think we will do at least $2B in Q3 and Q4.    And should do $1.5 to $2B in Q2.....  It's possible we could do $6.5 to $7.5B if USA gets going on 110 million and approves booster faster for additional orders. 
 
Also, could get more orders now from India and end of year boosters for China.....booster.

@Bilvo  this was Jan. 2022 .. India cleared it for their use 
https://www.moneycontrol.com/news/trends/health-trends/about-1-crore-doses-of-siis-covovax-cleared-by-govt-lab-for-public-use-testing-of-bio-es-corbevax-to-begin-7902671.html

Nearly one crore doses of the newly approved Covid-19 vaccine, Covovax, have been dispatched after the final round of quality and safety checks at the Central Drugs Laboratory (CDL), News18.com has learnt. Expanding India's vaccine basket, the Drugs Controller General of India (DCGI) on December 28 had approved the Serum Institute's Covovax and Biological E's Corbevax.

Moneycontrol

About 1 crore doses of SII's Covovax cleared by govt lab for public use, testing of Bio E's Corbevax to begin

  this was Jan. 2022 .. India cleared it for their use 


@ay8888 Not so loud there.  Someone might take it wrong and begin a buying spree with some serious buying.  That&#39;s what it&#39;ll take now that most of the retail traders have lost interest.  I think we have to wait for institutional traders to begin adding to positions.  I&#39;m not sure what they are waiting on.  But sales do look good, but with unfortunately deliveries are more concerning right now.  They have to complete orders.  If I were Vanguard or Blackrock, that what&#39;s I&#39;d be watching.

 Not so loud there.  Someone might take it wrong and begin a buying spree with some serious buying.  That's what it'll take now that most of the retail traders have lost interest.  I think we have to wait for institutional traders to begin adding to positions.  I'm not sure what they are waiting on.  But sales do look good, but with unfortunately deliveries are more concerning right now.  They have to complete orders.  If I were Vanguard or Blackrock, that what's I'd be watching.

George Snodgrass

@ay8888 I hope so and some more surprises for Q1. If Serum keeps there pledge/recommitment Starting in April 1 we should have a great year with or without USFDA!

 I hope so and some more surprises for Q1. If Serum keeps there pledge/recommitment Starting in April 1 we should have a great year with or without USFDA!